Compositions and methods for treating hepatitis b virus infection
US-2024092872-A1 · Mar 21, 2024 · US
Hepadnaviridae (F), e.g. hepatitis B virus
Hepadnaviridae (F), e.g. hepatitis B virus · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/082 |
| Official title | Hepadnaviridae (F), e.g. hepatitis B virus |
| Display label | Hepadnaviridae (F), e.g. hepatitis B virus |
| Total patents | 153 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 9 |
| 2016 | 12 |
| 2017 | 12 |
| 2018 | 12 |
| 2019 | 16 |
| 2020 | 9 |
| 2021 | 16 |
| 2022 | 17 |
| 2023 | 19 |
| 2024 | 12 |
| 2025 | 14 |
| 2026 | 5 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Antibody against hepatitis b surface antigen and use thereof
US-2019389939-A1 · Dec 26, 2019 · US
Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus
US-10507240-B2 · Dec 17, 2019 · US
Antibodies and fragments thereof that bind hepatitis b virus protein x
US-2019309052-A1 · Oct 10, 2019 · US
Chimeric antigen receptor therapy with reduced cytotoxicity for viral disease
US-2019307798-A1 · Oct 10, 2019 · US
Cytomegalovirus antigens and uses thereof
US-2019276498-A1 · Sep 12, 2019 · US
Antibody based gene therapy with tissue-directed expression
US-2019225673-A1 · Jul 25, 2019 · US
Fc variants with altered binding to FcRn
US-10336818-B2 · Jul 2, 2019 · US
Cell culture additives and their use for increased bioprotein production from cells
US-2019177402-A1 · Jun 13, 2019 · US
Cell culture additives and their use for increased bioprotein production from cells
US-10280217-B2 · May 7, 2019 · US
Polypeptides and antibodies for treating HBV infection and related diseases
US-10246494-B2 · Apr 2, 2019 · US
Glucagon-Like Peptide 1 Receptor Agonists and Uses Thereof
US-2019091296-A1 · Mar 28, 2019 · US
Antibodies that potently neutralize hepatitis b virus and uses thereof
US-2019016785-A1 · Jan 17, 2019 · US
Methods and reagents for creating monoclonal antibodies
US-2019002532-A1 · Jan 3, 2019 · US
Cytomegalovirus antigens and uses thereof
US-10167321-B2 · Jan 1, 2019 · US
Novel means and methods for treating hbv infection and associated conditions
US-2018362649-A1 · Dec 20, 2018 · US
Methods and compositions for eliciting an immune response against hepatitis b virus
US-2018243407-A1 · Aug 30, 2018 · US
Means and methods for treating HBV infection and associated conditions
US-10059767-B2 · Aug 28, 2018 · US
Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE
US-2018222965-A1 · Aug 9, 2018 · US
Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production method
US-2018179298-A1 · Jun 28, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/082?
- CPC C07K16/082 is the Cooperative Patent Classification code for “Hepadnaviridae (F), e.g. hepatitis B virus.”
- How many patents are filed under CPC C07K16/082 (Hepadnaviridae (F), e.g. hepatitis B virus)?
- Our database includes 153 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/082 growing?
- Publication counts under this code: 12 in 2024 vs 14 in 2025 (latest complete years).